Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
TENX
#3079
Tenax Therapeutics, Inc. - Common Stock
15.3
4
USD
-0.01%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.41%
Monthly Change
+36.23%
6 month change
-4.60%
Year Change
+103.18%
Previous Close
15.5
6
Open
15.3
4
Low
15.3
4
High
15.3
4
Volume
34
Markets
US Stock Market
Healthcare
Biotechnology
TENX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
TTM
Cash from operating activities
-6.97 M
-6.26 M
-9.15 M
-13.41 M
-9.31 M
-38.14 M
Cash from investing activities
0
0
0
—
—
—
Cash from financing activities
23.56 M
278 K
3.06 M
11.61 M
30.5 M
45.45 M
Free cash flow
-6.97 M
-6.26 M
-9.15 M
-13.41 M
-9.31 M
-38.14 M
News
Tenax Therapeutics: 'Hold' TNX-103 Data August 2026 - But With Caution Ahead (NASDAQ:TENX)
Tectonic Therapeutics: Currently In A Catalyst Vacuum (NASDAQ:TECX)
Cantor Fitzgerald initiates Tenax Therapeutics stock with overweight rating
Tenax Therapeutics stock gains as trial enrollment complete
Micron and BioNTech among market cap stock movers on Tuesday
Micron and Palantir among market cap stock movers on Tuesday
Tenax Therapeutics stock holds at Outperform at Leerink Partners
Tenax Therapeutics: Some Future Potential (NASDAQ:TENX)
Tenax Therapeutics Stock: A Speculative Buy (NASDAQ:TENX)
Tenax: Lower Variance In Phase 3 Has "Loaded The Dice" For An Asymmetric Repricing
Tesla, Goldman Sachs among market cap stock movers on Monday
Tenax Therapeutics’ phase 3 LEVEL study confirms enrollment target